Precision Medicine is the fastest growing segment fueling the growth of Personalized Genomics Market

 Market Overview:

Personalized genomics refers to technologies that analyze a person's DNA, RNA, proteins, and other molecular markers for diagnostic, prognostic and therapeutic purposes. It provides precise information on an individual's genetic make-up and biological pathways relevant to disease. This helps in disease diagnostics, drug development and treatment decisions.

The personalized genomics market is estimated to be valued at US$ 9.14 Bn in 2023 and is expected to exhibit a CAGR of 7.3 % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
Increasing adoption of direct-to-consumer genetic testing: Direct-to-consumer genetic testing is offering genetic testing directly to individuals, without involving a healthcare provider. It provides testing for ancestry, disease risks and other characteristics through mail-in DNA collection kits or saliva collection. This has boosted the adoption of personalized genomics. Lower costs and rapid advancements in next-generation sequencing technologies: Next-generation sequencing technologies has enabled large-scale, high-throughput and low-cost DNA sequencing. This has reduced the cost of whole genome sequencing from several million dollars in 2007 to around $1,000 in 2018 and is expected to decrease further over the forecast period. Such reduced costs are fueling the adoption of personalized genomics services.

Segment Analysis
The global personalized genomics market is fragmented into two key segments including NGS services and DNA sequencing. The NGS services segment currently dominates the market due to increasing preferences of consumers towards genetic screening and analysis. NGS services provide detailed analysis of individuals' genomic information and help in developing customized treatment and dietary plans.

Key Takeaways
The Global Personalized Genomics Market Size is expected to witness high growth, exhibiting CAGR of 7.3% over the forecast period, due to increasing prevalence of chronic diseases and rising awareness regarding personalized medicines.

Regional analysis: North America is expected to dominate the global personalized genomics market owing to rising healthcare expenditure and increasing adoption of advanced genomic technologies in the region. Asia Pacific is anticipated to exhibit fastest growth over the forthcoming years attributed to growing elderly population, improving healthcare facilities and rising disposable incomes in countries like China and India.

Key players: Key players operating in the personalized genomics market include 23andMe, Ancestry, Mapmygenome, Helix, MyHeritage, Gene by Gene, Pathway Genomics, Veritas Genetics, Xcode, Color Genomics, Positive Biosciences, Futura Genetics, Myriad Genetics, Quest Diagnostics, Laboratory Corporation of America, Illumina, Thermo Fisher Scientific, Qiagen, Genomic Health and Nebula Genomics. 23andMe and Ancestry currently dominates the direct-to-consumer genetic testing segment.

 

Get more insights on this topic:

https://www.dailyprbulletin.com/personalized-genomics-market-size-forecast/

Comments

Post a Comment

Popular posts from this blog

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc
Read more

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial managemen
Read more